Home Reimbursed medicines Lenvatinib
Lenvatinib — maximum prices and reimbursement
The CANAMED catalogue contains 48 medicines with the active substance Lenvatinib, from 3 manufacturers. Below you can see each entry with the brand name, the manufacturer, the maximum retail price and the prescription status — plus live pharmacy prices, where we track them.
In short: for the active substance Lenvatinib there are 48 authorised medicines in the CANAMED catalogue, with maximum retail prices between 3493.95 and 6923.04 RON, from 3 manufacturers. The reimbursement percentage depends on the CNAS sublist each product is placed on (A 90%, B 50%, C1/C2 100%, D 20%) and applies to the reference price, not to the shelf price. The maximum price is the legal cap — pharmacies may sell below it, so it is worth comparing the real price before you go. Latest import: 2026-11-03.
Data verified on from public sources (OpenStreetMap, chain websites, ANM/MS) — updated daily.
CANAMED catalogue
All medicines with Lenvatinib
Maximum retail price = the legal selling cap. Sorted by price, lowest first.
| Brand name | Manufacturer | Maximum price | Reimbursement | Prescription |
|---|---|---|---|---|
| LENTULIL 4 mg | SYNTHON HISPANIA S.L. - SPANIA | 3493.95 RON | not reimbursed | PR |
| LENTULIL 10 mg | SYNTHON HISPANIA S.L. - SPANIA | 4525.34 RON | not reimbursed | PR |
| LENVIMA 4 mg | EISAI GMBH - GERMANIA | 5336.29 RON | not reimbursed | PR |
| LENVIMA 10 mg | EISAI GMBH - GERMANIA | 6923.04 RON | not reimbursed | PR |
| KISPLYX 10 mg | EISAI GMBH - GERMANIA | — | not reimbursed | PR |
| KISPLYX 10 mg | EISAI GMBH - GERMANIA | — | not reimbursed | PR |
| KISPLYX 10 mg | EISAI GMBH - GERMANIA | — | not reimbursed | PR |
| KISPLYX 4 mg | EISAI GMBH - GERMANIA | — | not reimbursed | PR |
| KISPLYX 4 mg | EISAI GMBH - GERMANIA | — | not reimbursed | PR |
| KISPLYX 4 mg | EISAI GMBH - GERMANIA | — | not reimbursed | PR |
| LENTULIL 10 mg | SYNTHON HISPANIA S.L. - SPANIA | — | not reimbursed | PR |
| LENTULIL 10 mg | SYNTHON HISPANIA S.L. - SPANIA | — | not reimbursed | PR |
| LENTULIL 10 mg | SYNTHON HISPANIA S.L. - SPANIA | — | not reimbursed | PR |
| LENTULIL 10 mg | SYNTHON HISPANIA S.L. - SPANIA | — | not reimbursed | PR |
| LENTULIL 10 mg | SYNTHON HISPANIA S.L. - SPANIA | — | not reimbursed | PR |
| LENTULIL 10 mg | SYNTHON HISPANIA S.L. - SPANIA | — | not reimbursed | PR |
| LENTULIL 10 mg | SYNTHON HISPANIA S.L. - SPANIA | — | not reimbursed | PR |
| LENTULIL 10 mg | SYNTHON HISPANIA S.L. - SPANIA | — | not reimbursed | PR |
| LENTULIL 10 mg | SYNTHON HISPANIA S.L. - SPANIA | — | not reimbursed | PR |
| LENTULIL 10 mg | SYNTHON HISPANIA S.L. - SPANIA | — | not reimbursed | PR |
| LENTULIL 10 mg | SYNTHON HISPANIA S.L. - SPANIA | — | not reimbursed | PR |
| LENTULIL 4 mg | SYNTHON HISPANIA S.L. - SPANIA | — | not reimbursed | PR |
| LENTULIL 4 mg | SYNTHON HISPANIA S.L. - SPANIA | — | not reimbursed | PR |
| LENTULIL 4 mg | SYNTHON HISPANIA S.L. - SPANIA | — | not reimbursed | PR |
| LENTULIL 4 mg | SYNTHON HISPANIA S.L. - SPANIA | — | not reimbursed | PR |
| LENTULIL 4 mg | SYNTHON HISPANIA S.L. - SPANIA | — | not reimbursed | PR |
| LENTULIL 4 mg | SYNTHON HISPANIA S.L. - SPANIA | — | not reimbursed | PR |
| LENTULIL 4 mg | SYNTHON HISPANIA S.L. - SPANIA | — | not reimbursed | PR |
| LENTULIL 4 mg | SYNTHON HISPANIA S.L. - SPANIA | — | not reimbursed | PR |
| LENTULIL 4 mg | SYNTHON HISPANIA S.L. - SPANIA | — | not reimbursed | PR |
| LENTULIL 4 mg | SYNTHON HISPANIA S.L. - SPANIA | — | not reimbursed | PR |
| LENTULIL 4 mg | SYNTHON HISPANIA S.L. - SPANIA | — | not reimbursed | PR |
| LENVATINIB STADA 10 mg | STADA ARZNEIMITTEL AG - GERMANIA | — | not reimbursed | PR |
| LENVATINIB STADA 10 mg | STADA ARZNEIMITTEL AG - GERMANIA | — | not reimbursed | PR |
| LENVATINIB STADA 10 mg | STADA ARZNEIMITTEL AG - GERMANIA | — | not reimbursed | PR |
| LENVATINIB STADA 10 mg | STADA ARZNEIMITTEL AG - GERMANIA | — | not reimbursed | PR |
| LENVATINIB STADA 10 mg | STADA ARZNEIMITTEL AG - GERMANIA | — | not reimbursed | PR |
| LENVATINIB STADA 10 mg | STADA ARZNEIMITTEL AG - GERMANIA | — | not reimbursed | PR |
| LENVATINIB STADA 4 mg | STADA ARZNEIMITTEL AG - GERMANIA | — | not reimbursed | PR |
| LENVATINIB STADA 4 mg | STADA ARZNEIMITTEL AG - GERMANIA | — | not reimbursed | PR |
| LENVATINIB STADA 4 mg | STADA ARZNEIMITTEL AG - GERMANIA | — | not reimbursed | PR |
| LENVATINIB STADA 4 mg | STADA ARZNEIMITTEL AG - GERMANIA | — | not reimbursed | PR |
| LENVATINIB STADA 4 mg | STADA ARZNEIMITTEL AG - GERMANIA | — | not reimbursed | PR |
| LENVATINIB STADA 4 mg | STADA ARZNEIMITTEL AG - GERMANIA | — | not reimbursed | PR |
| LENVIMA 10 mg | EISAI GMBH - GERMANIA | — | not reimbursed | PR |
| LENVIMA 10 mg | EISAI GMBH - GERMANIA | — | not reimbursed | PR |
| LENVIMA 4 mg | EISAI GMBH - GERMANIA | — | not reimbursed | PR |
| LENVIMA 4 mg | EISAI GMBH - GERMANIA | — | not reimbursed | PR |
Prescription status key:
- PR — With a medical prescription (PR)
This catalogue does not record the reimbursement percentage per product. Reimbursement is set through the CNAS sublists — A 90%, B 50%, C1/C2 100%, D 20% of the reference price — see the full explanation of the sublists or ask the pharmacist for the exact placement.
Live pharmacy prices
Products with Lenvatinib in our comparator
Shelf prices collected from the large chains — see on each product page where it is cheapest.
Good to know
How to read the maximum price
The CANAMED maximum retail price is the legal cap approved by the Ministry of Health — the pharmacy may sell for less, never for more. If the medicine is reimbursed, the sublist percentage (A 90%, B 50%, C1/C2 100%, D 20%) applies to the reference price of the therapeutic group, usually calculated from the cheapest product with the same INN — which is why your contribution can differ from one brand to another, even for the same active substance. The electronic prescription automatically shows the exact amount to pay; for non-prescription shelf prices, use the HartaFarmacii comparator.
CANAMED catalogue
Other active substances in the catalogue
- Lenalidomid
- Lacosamid
- Levetiracetam
- Lidocain
- Levofloxacin
- Levothyroxin
- Levocetirizin
- Losartan
- Lamotrigin
- Letrozol
See also the full list of reimbursed medicines, with an alphabetical index of all active substances.
Frequently asked questions
FAQ · Lenvatinib
-
Is Lenvatinib reimbursed?
Reimbursement for Lenvatinib depends on the CNAS sublist the prescribed product is placed on (A 90%, B 50%, C1/C2 100%, D 20%) and on the reference price of the therapeutic group — not on the shelf price. The electronic prescription automatically shows the sublist and your contribution; ask the doctor or pharmacist for your exact situation. -
What is the CANAMED maximum price for Lenvatinib?
The maximum retail prices (the CANAMED legal cap) for medicines with Lenvatinib are between 3493.95 and 6923.04 RON. No pharmacy may sell above the maximum price, but it may sell below it — compare real prices with the HartaFarmacii comparator. -
What percentage of Lenvatinib is reimbursed?
The percentage depends on the CNAS sublist: A 90% (common chronic diseases), B 50% (partial reimbursement), C1 and C2 100% (serious chronic diseases and national programmes), D 20%. The percentage applies to the reference price set by CNAS, not to the shelf price, so you may pay a difference even for a “100% reimbursed” medicine. You can see the exact placement on the electronic prescription. -
How many medicines with Lenvatinib are in the CANAMED catalogue?
The CANAMED catalogue holds 48 authorised medicines with the active substance Lenvatinib — different brand names, strengths and pharmaceutical forms. You will find them all, with maximum price and prescription status, in the table on this page. Latest CANAMED import into the HartaFarmacii database: 2026-11-03.
Before you go